Doctorate at Curtin University, Australia
Professional Profile
Summary:
Dr. Hani Al-Salami is a distinguished clinician pharmacist, entrepreneur, academic, and inventor renowned for his innovative contributions in pharmaceutical sciences and biotechnology. With a career marked by impactful research, entrepreneurial ventures, and academic leadership, he has earned recognition as one of the top scientists globally. His pioneering work includes the development of novel drug delivery systems, particularly in utilizing bile acids for targeted drug delivery, and his research spans a wide range of therapeutic areas, from diabetes to neurodegenerative diseases.
👩🎓Education:
- Ph.D. in Pharmacy, Otago School of Pharmacy, New Zealand (2006-2009)
- Postdoctoral Researcher at McGill University and Micropharma Ltd, Montreal (2009-2011)
- Graduated from the School of Pharmacy at Otago University, New Zealand (2001)
Professional Experience:
Research Interests:
- Drug delivery systems and nanotechnology applications in medicine
- Development of innovative therapies for various diseases, including diabetes, neurodegenerative disorders, and hearing loss
- Utilization of bile acids for targeted drug delivery, particularly into the brain
- Investigating the pharmacological effects of probucol and other therapeutic agents
- Translational research bridging bench-to-bedside entrepreneurship for medical innovation
Paper Title: Polydimethylsiloxane Organic–Inorganic Composite Drug Reservoir with Gliclazide
- Authors: Gedawy, A.; Al-Salami, H.; Dass, C.R.
- Journal: International Journal of Molecular Sciences
- Volume: 25
- Pages: 3991
- Year: 2024
- Citations: 1
Paper Title: The therapeutic potential of probucol and probucol analogues in neurodegenerative diseases
- Authors: Sharif, A.; Mamo, J.; Lam, V.; Luna, G.; Takechi, R.
- Journal: Translational Neurodegeneration
- Year: 2024
Paper Title: Probucol-bile acid based nanoparticles protect auditory cells from oxidative stress: an in vitro study
- Authors: Wagle, S.R.; Kovacevic, B.; Ionescu, C.M.; Mooranian, A.; Al-Salami, H.
- Journal: Therapeutic Delivery
- Year: 2024
Paper Title: Biochemical changes to the inner ear contributing to diabetes-induced hearing loss: possible pharmacological targets for therapy
- Authors: Gedawy, A.; Al-Salami, H.; Dass, C.R.
- Journal: Journal of Pharmacy and Pharmacology
- Year: 2024
Paper Title: Synergy between PEDF and Doxorubicin in Breast Cancer Cells: Effects on Metastatic and Metabolic Pathways
- Authors: Abooshahab, R.; Al-Salami, H.; Dass, C.R.
- Journal: International Journal of Molecular Sciences
- Year: 2024